PuSH - Publication Server of Helmholtz Zentrum München

Pastore, F. ; Greif, P.A. ; Schneider, S.* ; Ksienzyk, B.* ; Mellert, G.* ; Zellmeier, E.* ; Braess, J.* ; Sauerland, C.M.* ; Heinecke, A.* ; Krug, U.* ; Berdel, W.E.* ; Buechner, T.* ; Woermann, B.J.* ; Hiddemann, W. ; Spiekermann, K.

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

PLoS ONE 9:e109759 (2014)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
NPM1 mutations represent frequent genetic alterations in patients with acute myeloid leukemia (AML) associated with a favorable prognosis. Different types of NPM1 mutations have been described. The purpose of our study was to evaluate the relevance of different NPM1 mutation types with regard to clinical outcome. Our analyses were based on 349 NPM1-mutated AML patients treated in the AMLCG99 trial. Complete remission rates, overall survival and relapse-free survival were not significantly different between patients with NPM1 type A or rare type mutations. The NPM1 mutation type does not seem to play a role in risk stratification of cytogenetically normal AML.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
ISSN (print) / ISBN 1932-6203
Journal PLoS ONE
Quellenangaben Volume: 9, Issue: 10, Pages: , Article Number: e109759 Supplement: ,
Publisher Public Library of Science (PLoS)
Publishing Place Lawrence, Kan.
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) CCG Pathogenesis of Acute Myeloid Leukemia (KKG-KPL)